Last week, the US government announced $2 billion in investments in quantum computing companies, allocating $100 million each to a range of startups in exchange for equity in the companies. Those could be make-or-break investments for many companies that are likely years away from a product that could see widespread use. But a member of the US Congress is now arguing that those deals are illegal, as Congress did not allocate the money for this purpose—instead, it was meant to support public research in semiconductors. But the biggest chunk of money would go to a company that likely wouldn't exist if it weren't for the government's backing. Anderon will be set up with a billion dollars each from IBM and the government and will inherit personnel and IP from IBM. It will serve as a foundry for fabricating quantum processing units and will contract its services out to IBM and any other company that wants access to cutting-edge hardware. Is any of this legal? Zoe Lofgren (D–Calif.), the ranking member of the House Science, Space, and Technology Committee, made it clear that she is not happy with how the government is using its money to support this technology. Read full article Comments

Welcome to the Mideast Money newsletter, I’m Adveith Nair . Join us each week as my team and I chronicle the intersection of money and power in a region that’s become one of the most influential in global finance. You can sign up here . This week: Saudi Arabia sees unexpected gains from the Iran war, the Public Investment Fund looks to build a logistics giant , and the kingdom’s bridge to Trump falters. But first, let’s start in Abu Dhabi. The Strait of Hormuz has been blocked for almost three months, choking off one of the world’s most important trade routes and forcing Gulf economies into an urgent scramble to keep supply flowing. Some producers have leaned on stealth shipping and rerouting, though many use leased tankers and are constrained by the risk appetite of shipowners. Here, Abu Dhabi’s state energy firm has an edge , as it uses vessels controlled by a subsidiary. That’s made Abu Dhabi National Oil Co. among the most successful producers when it comes to moving supplies out of the Middle East, my colleagues Serene Cheong , Stephen Stapczynski and Weilun Soon report. Adnoc has also been sending recently-exited ships back into the Persian Gulf for more cargoes — so-called shuttle runs that can keep oil and fuels flowing. Once through Hormuz, the vessels typically transfer their cargoes to clients’ tankers in safer waters off Fujairah or Sohar, or sail to India’s west coast. Qatar, too, has managed to get some energy supplies out of the strait in recent days, alongside neighboring Saudi Arabia, which has the added advantage of a pipeline that runs across the kingdom to an alternative port on the Red Sea coast. Those ports on the Red Sea have grown in importance since since the war began, handing Saudi Arabia an unexpected win. Oman is emerging as another beneficiary. Also Read : Saudi Crown Prince MBS Scores Unexpected Wins During Iran War While the US and Iran appear to have inched closer to a deal to reopen the strait, the mechanics of its future operation ...

Leonid Andronov/iStock Editorial via Getty Images No two utilities are identical. Often, utility companies can be compared to one another, especially if they're regulated or non-regulated utilities. There are some comparisons there if they mean in those two camps. Some companies try to expand into being both a regulated and non-regulated utility or even a multi-faceted utility focusing on natural gas, water, and power or some combination of the three. However, there is one universal consideration for regulated utilities, and even in some regard for non-regulated utilities, and that would be the difficulty of the governmental structure where they operate. Some regions of the United States, like Florida, are very regulatorily friendly, meaning that regulators typically are agreeable to the pricing increases and return on equity percentages that utilities are seeking. This is one reason why NextEra Energy ( NEE ) has been able to grow so successfully over the years. It has benefited from strong regulatory support. However, if you go to the other side of the United States of America, on the West Coast, it is considered to be an extremely unfriendly regulatory environment. Regulators are more concerned about consumers and the impacts that utility operations will have on their wallets than some of their East Coast peers. Often regulators are also more concerned about environmentally friendly practices or renewable energy, which are often more expensive and produce less power than other opportunities that exist. At the end of the day, a regulated utility cannot control how their regulators are going to operate, and this can cause some utilities to sell at a discounted valuation compared to others, especially if those utilities exist on the West Coast, where there are regulatory-unfriendly environments and often higher risks for liability for wildfires. The government may not have done a good job taking care of their forests , but they sure as anything like to blame a utili...

Getty Images Introduction On April 26th, Ligand Pharmaceuticals Incorporated ( LGND ) announced their agreement to acquire XOMA Royalty Corporation ( XOMA ). Terms in the announcement included: Ligand Pharmaceuticals Incorporated (LGND) and XOMA Royalty Corporation (“XOMA Royalty”) (Nasdaq: XOMA), both biotechnology royalty aggregators, today announced that the companies have entered into a definitive agreement under which Ligand will acquire XOMA Royalty for $39.00 per share of common stock in cash, for a total equity value of approximately $739 million. XOMA Royalty stockholders are expected to separately receive one non-transferable Contingent Value Right (“CVR”) per share entitling the holder to receive a portion of 75% of the net proceeds that may result from certain pending litigation at XOMA Royalty. XOMA Royalty’s Series X Convertible Preferred Stock is expected to be converted into shares of common stock at its stated fixed price prior to closing, whereas the outstanding shares of Series A Preferred Stock and Series B Preferred Stock are expected to be redeemed. The transaction is expected to close in the third quarter of 2026 and to be immediately accretive to Ligand earnings per share. Source: Acquisition press release . This will be the last review of these, as I am expecting them to be redeemed. XOMA Corporation 8.375% DP PFD B ( XOMAO ). XOMA Corporation 8.625% CUM PERP PFD SER A ( XOMAP ). Based on the change in owners, XOMAO now rates a Strong Buy for its 7+% YTC. The owner of XOMAP should hold as the YTC is much better than what a 5-month CD offers. Ligand Pharmaceuticals review Data by YCharts Ligand provides this description of the company (edited): Ligand is a biopharmaceutical company that invests in the groundbreaking medicines of today and tomorrow. We fund the clinical development and commercialization of high-value programs that can improve and extend lives around the world. Our diversified portfolio of royalty assets generates consistent an...

Grail 's (NASDAQ: GRAL) share price decline of over 20% so far in 2026 is understandable. After all, when a multicancer early detection (MCED) test company misses a primary endpoint of a landmark three-year trial, investors immediately price in difficulties receiving Food and Drug Administration (FDA) approval, let alone receiving insurance coverage for a test that failed in a trial. That said, there's still a powerful case for the stock, and a very strong catalyst could be about to be unleashed, propelling it higher. The investment case for the stock centers on its MCED test, Galleri, which completed a three-year, 142,000-person trial with England's National Health Service (NHS). Grail released the top-line results from the trial in mid-February and promptly disappointed the market by revealing it had missed its primary endpoint. Early-stage cancers (Stage I and Stage II) are far easier and cheaper to treat than later-stage cancers (Stage III and Stage IV). The latter two are defined by cancer that has spread to surrounding tissues (Stage III) or to another organ (Stage IV). Continue reading

Dr. Oz Fires Back After Joy Behar's TrumpRx Meltdown Authored by David Manney via PJMedia.com, Dr. Mehmet Oz, the 17th administrator of the Centers for Medicare & Medicaid Services , answered Joy Behar after the longtime co-host of The View warned viewers about President Donald Trump's prescription drug initiative. Behar said once Trump puts his name on prescriptions, “We're all going to die.” Joy Behar claims "we're all going to die" because Trump wants to lower drug prices with TrumpRX. pic.twitter.com/uG458SU1AD — MRC NewsBusters (@newsbusters) May 19, 2026 She also reached for Trump's past business failures, as if cheaper medicine belongs in the same dusty joke drawer as casino chatter and late-night monologue scraps. Dr. Oz didn't need a medical chart to spot the problem, saying TrumpRx.gov still has no medication for Trump Derangement Syndrome (TDS), though they're working on it. https://t.co/8XMXPxEXtl pic.twitter.com/1brcfTOarK — DrOzCMS (@DrOzCMS) May 20, 2026 His joke landed because Behar's reaction sounded less like analysis and more like a smoke alarm installed over a toaster sitting near a burning pile of pine boughs: loud, frantic, and not especially useful once breakfast remains intact. President Trump announced on May 18 that TrumpRx would expand with over 600 generic medications. The AP reports : The beefed-up website is the Trump administration’s answer to criticism from Democrats who have called TrumpRx performative and noted that many of the brand-name drugs it has featured are cheaper with insurance or have lower-cost generic versions sold elsewhere. It also marks an effort to respond to a top voter concern for November’s midterm elections: affordability. Health costs are a worry for many Americans, an issue compounded by the Republican-led Congress’ recent cuts to Medicaid and the expiration of enhanced Affordable Care Act subsidies this year that sent some people’s premiums skyrocketing. The expansion is made possible by partnerships with othe...

Jardine Matheson, an investment company headquartered in Hong Kong, announced on Monday the A$3.4 billion (US$2.4 billion) acquisition of the entire stake of an Australian diagnostic and teleradiology group. The acquisition of I-MED Radiology Network, which spans 215 diagnostic imaging clinics across metropolitan and regional communities in Australia and New Zealand, is one of Jardine Matheson’s largest in recent years, following its full takeover of the luxury hotel unit Mandarin Oriental in a buyout completed in January, which valued the unit at US$4.2 billion. The deal marked “a significant step” for Jardine Matheson’s “strategic evolution as an Asia-Pacific-focused investor and control owner of high-quality businesses in the region”, the investment company said in a statement. The deal also covered I-MED’s minority interest in Harrison.ai, which develops radiology AI solutions , including CT brain and chest scans. Advertisement “The investment in I-MED is consistent with Jardines’ capital allocation priorities to invest for control in market-leading assets and to expand Jardines into strong growth verticals such as healthcare diagnostics,” the statement said. “Jardines is excited to partner with Dr Shrey Viranna, Clare Battellino and the outstanding doctors and clinicians of I-MED,” said Lincoln Pan, CEO of the Jardine Matheson, whose assets span real estate, retail and hotels with stakes in Hongkong Land Wellcome supermarket chain and 7-Eleven in Hong Kong, Macau and Singapore owner DFI Retail Group and Mandarin Oriental. Both Wellcome and 7-Eleven are owned and operated by DFI. Advertisement “I-MED have a first-class management team, which have not only driven consistent earnings growth, but have stayed at the cutting edge of innovation, including bold steps into AI which will allow them to strengthen their market-leading position, while still supporting high clinical standards,” Pan said, adding that Jardine Matheson’s goal is to support I-MED in the next pha...

广康生化公告，公司股东华拓至远叁号与华拓至盈贰号的减持股份计划已于2026年5月24日届满。期间，华拓至远叁号通过集中竞价和大宗交易方式累计减持37.54万股，占公司总股本的0.5073%。华拓至盈贰号通过集中竞价方式累计减持49.44万股，占公司总股本的0.6681%。两股东合计减持86.98万股，占公司总股本的1.1754%。减持股份来源为公司首次公开发行股票前持有的股份。减持计划符合相关法律法规，未导致公司控制权变更。

5月25日 周一《新闻联播》要闻11条 2026-05-25 19:59:05 来源： 同花顺7x24快讯 分享 1、习近平举行仪式欢迎塞尔维亚总统访华； 2、习近平同塞尔维亚总统会谈； 3、习近平会见巴基斯坦总理； 4、李强会见塞尔维亚总统； 5、李强举行仪式欢迎巴基斯坦总理访华； 6、李强同巴基斯坦总理会谈； 7、王沪宁会见塞尔维亚总统； 8、全国人大常委会启动海南自由贸易港法、旅游法执法检查； 9、神舟二十三号载人飞船发射取得圆满成功两个乘组航天员会师太空； 10、各地各部门积极应对持续强降雨； 11、联播快讯：(1)第二十二届文博会闭幕；(2)五部门联合出台《超龄劳动者基本权益保障暂行规定》；(3)美国称与伊朗协议尚未完全谈妥；(4)俄称摧毁乌无人机乌称打击俄指挥所。(央视新闻)

《科创板日报》5月25日讯（记者 杨小小） 广东省级基金谱系再升级。 今日，广东省战略性新兴产业投资引导基金（以下简称“广东战新引导基金”）正式启动。据官方披露，该基金总规模达1000亿元，首期注册规模500亿元，是广东首支永续经营的公司制省级政府投资基金。 上述基金将采用“引导基金-母基金-子基金”三级架构，重点投向战略性新兴产业与未来产业，强化“投早、投小、投长期、投硬科技”。 另据基金揭牌现场披露的基金运营细节披露，该基金由省财政厅履行出资人职责；广东粤财基金管理有限公司负责运营管理；省发展改革委则负责对基金本身以及粤财作为GP的“人财物”管理。 现场签约仪式中，广东新能源产业基金、广东智能制造产业基金、广东智能家居产业基金、广东人工智能与机器人基金、广东新材料产业基金、广东具身智能产业基金、广东海洋经济产业基金、广州区域产业投资母基金、珠海区域产业投资母基金、东莞区域产业投资母基金、TCL华星光电T8项目、小鹏集团项目成功签约。 《科创板日报》记者注意到，广东战新引导基金的工商主体“广东省战略性新兴产业投资引导基金有限责任公司”，已于2025年12月底完成登记注册，目前已对粤港澳大湾区创业投资引导基金合伙企业（有限合伙）进行了出资。后者是国家创业投资引导基金首批设立的三个区域子基金之一。 事实上，广东并不缺产业引导基金。 早在2018年，广东省就发布了创新创业基金，并在次年发布的一份文件中强调，要发挥省创新创业基金引导作用，重点投向初创期、早中期创新型企业，引导更多社会资金助推创新创业。 此后，广东省还设立了半导体及集成电路产业投资基金。该基金也是由广东粤财基金管理有限公司作为管理人，两期基金目标总规模达到500亿元。 相比此前广东已有的产业基金体系，有创投业内人士对《科创板日报》记者分析，此次新设的战新引导基金最大的不同，在于其“永续制”“公司制”以及更强的省级统筹能力。“ 这意味着，广东正在尝试构建一个更长期、更市场化、更接近国家级产业资本逻辑的超级母基金平台。” 所谓“永续制”，在广东战新引导基金实践中具体指，建立不设固定存续期限的公司制基金，提出财政稳定投入和循环投资机制，本质解决的是政府基金“短钱长投”的痛点。值得一提的是，当前全球主流的主权基金采取的也是相似的长期资本模式。 为了适应新的基金运营机制，广东战新引导基金在制度和考核上也做了适配：政府...

鸿日达公告，控股股东、实际控制人王玉田及其一致行动人昆山豪讯宇企业管理有限公司计划自2026年6月17日至2026年9月16日，以大宗交易方式合计减持公司股份不超过412.71万股（占公司总股本比例1.9970%）。其中，王玉田拟减持不超过206.35万股（占公司总股本比例0.9985%），昆山豪讯宇拟减持不超过206.35万股（占公司总股本比例0.9985%），减持原因为股东自身资金需求，减持价格不低于公司首次公开发行股票发行价格。

宏昌科技公告，公司副总经理吴红平持股90000股，占0.068%；拟因个人资金需求，自公告披露之日起15个交易日后3个月内，以集中竞价方式减持不超过22500股，占0.017%。减持股份来源为2024年限制性股票激励计划第一个归属期归属的股票。

万辰集团公告，股东彭德建、范鸿娟提前结束减持计划。彭德建于2026.4.13-2026.5.11通过集中竞价及2026.4.14大宗交易合计减持40.66万股，占0.2153%；范鸿娟于2026.4.14大宗交易减持120万股，占0.6353%。减持后，彭德建持股2073.22万股，占10.5062%；范鸿娟持股30万股，占0.1520%。

文章提及标的 上大股份 -- 中航重机 -- 免责声明： 风险提示：本文内容仅供参考，不代表同花顺观点。同花顺各类信息服务基于人工智能算法，如有出入请以证监会指定上市公司信息披露平台为准。如有投资者据此操作，风险自担，同花顺对此不承担任何责任。

Matheus Nunes (Man City): Nunes enjoyed a superb season at full-back, starting more games (32) and playing more minutes (2,865) than in his first two seasons at the club combined (26 starts, 2,327 minutes). City were far better off with him in the starting XI - they won 66% (W21 D8 L3) of the games he started, compared to 33% without him (W2 D1 L3). Nunes completed more passes in the opposition half than any other player this season (1,153) while among full-backs he had the joint most open play assists (5), made the most line-breaking passes overall (275), as well as completing the most passes in the final third (600). He was also the full-back with the most ball carries (514) and carry distance - well over 5,000m. Gabriel (Arsenal): One of the odder statistics of 2025-26 is that Arsenal central defender Gabriel Magalhaes ended the season with more Premier League goals and assists combined than the likes of Jorgen Strand Larsen (5) and Bernardo Silva (6) and as many as Bournemouth striker Evanilson (7). Of his seven goal involvements (3 goals, 4 assists), six unsurprisingly came via set-pieces as the Brazilian caused chaos in opposition boxes, helping the Gunners to score a record 19 corner goals in 2025-26. It is, of course, at the other end where Gabriel really stands out, ending the season with 17 clean sheets, which was more than any other defender despite being absent from eight starting XIs in 2025-26. Arsenal conceded just 20 goals in 2,751 minutes with him on the pitch, an average of one every 138 minutes, which was the best by an Arsenal defender to play 2,000+ minutes since 2003-04, when Sol Campbell went 140 minutes between goals going in with him on the pitch. William Saliba (Arsenal): Alongside Gabriel, who else but Saliba? The pair are forging a legendary Premier League central defensive partnership, losing just 15 of the 117 games they've played together for Arsenal and the Gunners concede on average a goal every 44 minutes more frequently when they a...

Haussmann SIC SIF Haussmann (0P0001DXJT) 最新股票消息和頭條新聞 Yahoo 財經

Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for smaller, more agile players. These trade-offs can cause headaches for even the most seasoned professionals, which is why we started StockStory - to help you find high-quality companies that can grow their earnings no matter what. Keeping that in mind, here are three large-cap stocks whose momentum may slow and a few alternatives you should consider instead. Workday (WDAY) Market Cap: $31.65 billion Born from the vision of PeopleSoft founders after Oracle's hostile takeover of their previous company, Workday (NASDAQ:WDAY) provides cloud-based software for financial management, human resources, planning, and analytics to help organizations manage their business operations. Why Are We Hesitant About WDAY? Sales trends were unexciting over the last two years as its 14.1% annual growth was below the typical software company Estimated sales growth of 10.8% for the next 12 months implies demand will slow from its two-year trend Operating profits and efficiency rose over the last year as it benefited from some fixed cost leverage Workday is trading at $127.70 per share, or 2.8x forward price-to-sales. Dive into our free research report to see why there are better opportunities than WDAY. NXP Semiconductors (NXPI) Market Cap: $79.9 billion Spun off from Dutch electronics giant Philips in 2006, NXP Semiconductors (NASDAQ: NXPI) is a designer and manufacturer of chips used in autos, industrial manufacturing, mobile devices, and communications infrastructure. Why Does NXPI Fall Short? Sales tumbled by 2.5% annually over the last two years, showing market trends are working against its favor during this cycle Projected sales growth of 14.6% for the next 12 months suggests sluggish demand NXP Semiconductors’s stock price of $316.96 implies a valuation ratio of 19.2x forward P/E. If you’re...

格隆汇5月25日｜周一，一位知情官员透露，伊朗首席谈判代表卡利巴夫伊朗外长阿拉格齐已抵达多哈，正与卡塔尔首相举行会谈，商讨旨在结束冲突的潜在美伊协议。这位官员表示，此次磋商主要聚焦于霍尔木兹海峡局势以及伊朗的高浓缩铀储备问题。据该官员介绍，伊朗中央银行行长也随团出访，旨在探讨作为最终协议一部分、解冻伊朗被冻结资金的可能性。

半官方的法尔斯通讯社报道，伊朗央行行长Abdolnaser Hemmati前往卡塔尔，讨论释放被冻结资金的问题，作为经济委员会谈判的一部分。 法尔斯通讯社报道，卡塔尔代表团上周前往伊朗，斡旋伊美谈判。 责任编辑：江学思

鼎龙股份公告，公司控股子公司鼎泽新材料在CMP抛光液领域取得三项突破：①斩获头部逻辑芯片代工厂优秀供应商奖项；②铜阻挡层抛光液获得第三家客户批量订单；③SiC衬底抛光液成功落地批量订单，自研氧化铝磨料正式切入第三代半导体市场。公司已具备武汉年产5000吨抛光液、仙桃年产1万吨抛光液及1万吨研磨粒子产能。

India’s gas power generation has plunged to the lowest level in at least six years, with the Iran war hitting fuel shipments, straining electricity supplies at a time when a scorching summer is pushing demand to record highs. Peak electricity consumption surged to an unprecedented 270.8 gigawatts last week, rising for four straight days, as people cranked up air conditioners and other cooling appliances amid soaring temperatures. While daytime consumption was largely met with the help of solar generation, supplies struggled to keep pace with the surge in the night , also a record. Low output from gas-fired plants, hamstrung by fuel shortages caused by the war, worsened the pressure on the grid. Read More: India Calls for “Judicious” Use of Power as Heat Pushes Demand Gas-fired generators in India produced about 3.6 billion kilowatt hours of electricity between April and May 21 this year, the lowest for the period in at least six years, data from the power ministry showed. The output was about two-thirds of the production during the same period last year and just about half of that in 2024. The Strait of Hormuz has remained virtually shut with Iran and US enforcing blockades on a waterway that normally handles about a fifth of global LNG supply. India imported more than half of its LNG from Qatar and the UAE, but those shipments have almost dried in the last few months. While these stations bought the imported fuel from the Indian Gas Exchange to meet a part of the evening demand surge, generation was still below par. As a result, power supply fell short almost every night when demand peaked. The deficit, along with local grid breakdowns, have caused blackouts across the country, from the capital New Delhi to the most populated state of Uttar Pradesh in the north, as well as the heavily industrialized Tamil Nadu in the south. After fuel shortages and a series of energy price increases, the outages during a blistering summer underscore the rising toll from the conflic...

文章提及标的 欧科亿 -- 格林美 -- 免责声明： 风险提示：本文内容仅供参考，不代表同花顺观点。同花顺各类信息服务基于人工智能算法，如有出入请以证监会指定上市公司信息披露平台为准。如有投资者据此操作，风险自担，同花顺对此不承担任何责任。

格隆汇5月25日丨布伦特原油期货跌幅扩大至6%，报94.202美元/桶。

格隆汇5月25日丨安徽省人民政府印发《安徽省政府投资基金管理办法》。办法指出，政府投资基金根据不同类型实行差异化管理。对产业投资类基金，应根据产业类型、发展阶段、分布特点合理设置管理要求，突出支持重点产业和产业链关键环节，可放宽存续期至15年。对创业投资类基金，可适当提高政府出资比例、放宽存续期至20年、延长绩效考评周期至3—5年。

格隆汇5月25日丨鼎龙股份(300054.SZ)公告称，公司控股子公司鼎泽新材料在半导体CMP抛光液领域取得突破性进展：核心产品斩获头部晶圆厂客户优秀供应商奖项；铜阻挡层抛光液获得新客户批量订单；碳化硅衬底抛光液成功落地批量订单，自研磨料正式切入第三代半导体市场。公司已实现抛光液产品全品类布局，产能储备充足。本次涉及的抛光液产品里，搭载氧化铝研磨粒子的抛光液、铜制程抛光液（含铜及铜阻挡层抛光液）为晶圆制造关键耗材，亦是国内抛光液市场主流品类，预计两类产品在抛光液市场规模的金额占比分别超20%、45%，2026年国内合计市场规模突破40亿元。

智通财经获悉，加拿大能源部长蒂姆·霍奇森表示，他“高度确信”阿尔伯塔省油砂企业有能力承担建设碳捕集项目的成本，尽管这些企业一直抗议称，加拿大的气候法规正在削弱其全球竞争力。 加拿大总理卡尼领导的政府本月早些时候与阿尔伯塔省就工业碳价格路径达成协议。该机制要求高排放企业为碳排放付费，同时也会为减少温室气体排放的企业提供碳信用。 这项协议是推动价值165亿加元(约合120亿美元)的“Pathways”油砂碳捕集项目的重要一步。卡尼此前曾表示，这是批准一条通往加拿大 太平洋 沿岸的新原油 管道 的必要条件。然而，在过去数月的谈判过程中， 石油 公司开始公开表示，碳价格给加拿大能源行业带来了其他主要产油国并不存在的额外成本。 对此，霍奇森在接受 采访 时表示，在他看来，这些企业的主要不满在于，它们并未直接参与谈判。他表示：“现实情况是，联邦政府和省政府必须先就碳定价框架达成一致，之后才能让企业加入谈判桌。”“如今这一步已经完成，后续沟通将会展开。我高度确信，按照我们目前设计的结构，Pathways项目的成本是可以被轻松消化的。” 据悉，Pathways项目由五家最大的油砂公司牵头推进，其中包括Cenovus能源(CVE.US)、帝国石油(IMO.US)以及森科能源(SU.US)。项目将从多个设施中捕集二氧化碳，并通过超过400公里(249英里)的管道输送至阿尔伯塔省东部的储存中心，最终注入地下封存。 根据最新协议，Pathways项目目标是在未来二十年内逐步实现每年减少1600万吨碳排放。第一阶段计划于2035年前完成，届时将建成每年可减少600万吨排放的碳捕集能力。 霍奇森表示，希望到那时相关技术已取得重大进展，从而提供更多选择。他表示：“我认为你将看到一系列新技术不断变得越来越便宜，而这将为Pathways项目方创造更多选择。” 霍奇森举例称，直接空气捕集技术，以及燃烧前和燃烧后的碳封存技术，都可能改变行业未来的技术路径。他还表示，减排方式也可能包括使用小型模块化核反应堆为油砂项目供能。霍奇森表示：“如果你的热源来自核能，那么碳强度将大幅下降，因为你不再需要燃烧 天然气 。” 代表上述五家公司利益的油砂联盟总裁肯德尔·迪林表示，碳价格机制对加拿大石油行业而言仍然是一种“竞争劣势”，但他补充称，一条面向亚洲出口的新石油管道，将改变这一局面。他表示：“这就是附加价值，也是对...

aapsky/iStock via Getty Images Setting the Stage It is my belief that we all agree that the consensus view of the defense stock in 2026 is straightforward. This is based on the rising global military budgets, geopolitical tensions, and munitions drawdown being the structural tailwinds for defense primes. While this is the common view, I find it missing a more interesting and more differentiated argument for RTX Corporation ( RTX ) specifically. It is my take that RTX is not simply a defense contractor. Rather, it simultaneously operates one of the world’s two dominant commercial jet engine platforms (Pratt and Whitney’s GTF and V2500 family). Also, it operates the world’s largest commercial aerospace systems supplier, which is Collins Aerospace, and one of the top three US prime contractors (Raytheon). As the defense expenditure keeps soaring, RTX wins from the trend. When commercial air travel grows, the company also wins. With the company running both simultaneously, it follows that it is firing from both ends. With its stock trading at about $177 post-earnings overreaction to tariff concerns, amid a record $271 billion backlog that provides multiyear earnings visibility, I am rating RTX a buy with a $201.85 price target. The Macro Lens: Market & Industry Context Over the past couple of years, global defense spending has entered a structural upcycle that is historically unusual in its breadth. Europe, on the one hand, is rearming at the fastest pace since the Cold War as the NATO allies accelerate towards the 2% GDP commitment. On the other hand, the US DoD’s 2026 budget proposals sit at approximately $1 trillion . Reuters A notable trend is how this soaring defense expenditure is tilting towards high technology and precision systems . This entails missiles, air defense, electronic warfare, and autonomous platforms. Interestingly, this is exactly the category where Raytheon sits to leverage this massive market opportunity. In Q1 2026, RTX signed five landmark agre...

内蒙古兴业银锡矿业股份有限公司向港交所提交上市申请书 2026-05-25 19:52:08 来源： 同花顺7x24快讯 分享 文章提及标的 兴业银锡 --

锐科激光公告，公司高级管理人员曹磊女士此前披露的减持计划期限已届满。曹磊原计划减持不超过36282股（占公司总股本0.006%），在2026年5月19日至5月21日期间通过集中竞价方式合计减持12600股（占公司总股本0.0023%），减持均价分别为40.15元/股和41.2元/股。本次减持后，曹磊持有公司股份13.25万股，占公司总股本的0.0236%。

和顺电气公告，股东姚建华及一致行动人秦勇、姚尧合计持股24.09%共6212.08万股。2026年2月25日至5月20日，姚建华、秦勇通过集中竞价累计减持235.9万股，占0.91%，减持均价15.01元/股、15.81元/股、15.23元/股、13.01元/股。减持后三人合计持股5976.18万股，占23.18%，减持计划已完成，未触及要约收购且不影响公司控制权。